Advisory Services Network’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
Other funds holding LUCD
VCM
MCM
TSC
PCM
Advisory Services Network's LUCD Position: Q1 2026 in Review
Advisory Services Network opened a new position in Lucid Diagnostics (LUCD) in Q1 2026: 765 shares worth $880. The stake represents ﹤0.01% of the portfolio and ranks #4337 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in LUCD as recently as Q3 2025.
Advisory Services Network first reported a position in LUCD in Q4 2023 and has held it in 3 quarters since. The position peaked at $1.08K in Q4 2023. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.
- Advisory Services Network held 765 shares of Lucid Diagnostics worth $880 as of Q1 2026.
- Lucid Diagnostics was a new Advisory Services Network position in Q1 2026.
- Lucid Diagnostics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4337 holding.
- Advisory Services Network first reported a position in Lucid Diagnostics in Q4 2023 and has held it in 3 quarters since.
- Advisory Services Network's Lucid Diagnostics position peaked at $1.08K in Q4 2023.
- 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.
Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.